Stockscreener 앱 받기
70.14
0.34%
-0.24
시간 외 거래:
70.14
전일 마감가:
$70.38
열려 있는:
$70.2
하루 거래량:
553.46K
Relative Volume:
0.82
시가총액:
$2.96B
수익:
$17.39M
순이익/손실:
$-135.89M
주가수익비율:
-15.12
EPS:
-4.64
순현금흐름:
$-123.00M
1주 성능:
+7.63%
1개월 성능:
+29.10%
6개월 성능:
+58.98%
1년 성능:
+97.58%
1일 변동 폭
$67.77
$70.67
1주일 범위
$66.00
$70.78
52주 변동 폭
$34.67
$70.78
Tarsus Pharmaceuticals Inc Stock (TARS) Company Profile
명칭
Tarsus Pharmaceuticals Inc
전화
(949) 409-9820
주소
15440 LAGUNA CANYON ROAD, IRVINE
TARS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TARS
Tarsus Pharmaceuticals Inc
|
70.14 | 2.97B | 17.39M | -135.89M | -123.00M | -4.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Tarsus Pharmaceuticals Inc Stock (TARS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-02 | 재개 | Oppenheimer | Outperform |
| 2025-05-27 | 재개 | H.C. Wainwright | Buy |
| 2023-11-20 | 개시 | Goldman | Neutral |
| 2023-07-18 | 개시 | William Blair | Outperform |
| 2023-05-18 | 개시 | Guggenheim | Buy |
| 2022-08-01 | 개시 | Barclays | Overweight |
| 2021-12-21 | 개시 | H.C. Wainwright | Buy |
| 2021-11-23 | 개시 | Oppenheimer | Outperform |
| 2020-11-10 | 개시 | BofA Securities | Buy |
| 2020-11-10 | 개시 | Jefferies | Buy |
| 2020-11-10 | 개시 | Ladenburg Thalmann | Buy |
| 2020-11-10 | 개시 | Raymond James | Strong Buy |
모두보기
Tarsus Pharmaceuticals Inc 주식(TARS)의 최신 뉴스
Tarsus Pharmaceuticals Achieves 101.95% Annual Growth, Solidifying Status as Multibagger Stock - Markets Mojo
Using data models to predict Tarsus Pharmaceuticals Inc. stock movementWeekly Stock Report & Weekly Setup with High ROI Potential - newser.com
Applying big data sentiment scoring on Tarsus Pharmaceuticals Inc.Breakout Watch & Safe Capital Investment Plans - newser.com
How sentiment analysis helps forecast Tarsus Pharmaceuticals Inc.2025 EndofYear Setup & Expert Verified Movement Alerts - newser.com
Trend analysis for Tarsus Pharmaceuticals Inc. this weekInsider Buying & Breakout Confirmation Trade Signals - newser.com
Tarsus Pharmaceuticals Experiences Evaluation Revision Amid Strong Market Performance Indicators - Markets Mojo
Tarsus Pharmaceuticals Hits New 52-Week High of $70.58 - Markets Mojo
BofA Ups Price Target on Tarsus Pharmaceuticals to $85 From $80 - MarketScreener
Should you hold or exit Tarsus Pharmaceuticals Inc. nowQuarterly Market Summary & Stepwise Entry and Exit Trade Signals - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for Tarsus Pharmaceuticals (NASDAQ:TARS) - MarketBeat
Tarsus Pharmaceuticals stock hits all-time high at 69.6 USD By Investing.com - Investing.com Nigeria
Tarsus Pharmaceuticals stock hits all-time high at 69.6 USD - Investing.com
Tarsus Pharmaceuticals Hits New 52-Week High of $69.49 - Markets Mojo
Tarsus Pharmaceuticals Hits New 52-Week High of $68.00 - Markets Mojo
Tarsus Pharmaceuticals Inc Stock Analysis and ForecastPrice Momentum Alerts & Investment Recommendations You Can Trust - earlytimes.in
Tarsus Pharmaceuticals Hits Day High with 10.89% Surge in Stock Price - Markets Mojo
Tarsus Pharmaceuticals Hits New 52-Week High of $65.97, Surges 101% - Markets Mojo
Tarsus Pharmaceuticals (NASDAQ:TARS) Reaches New 52-Week HighWhat's Next? - MarketBeat
Tarsus Pharmaceuticals (TARS) Moves 10.9% Higher: Will This Strength Last? - Yahoo Finance
How Tarsus Pharmaceuticals Inc. stock reacts to inflationary pressures2025 Analyst Calls & Consistent Profit Trade Alerts - newser.com
How Tarsus Pharmaceuticals Inc. stock trades before earningsEarnings Recap Summary & Consistent Profit Trading Strategies - newser.com
Is Tarsus Pharmaceuticals Inc. forming a bottoming baseJuly 2025 Opening Moves & Advanced Technical Signal Analysis - newser.com
Will Tarsus Pharmaceuticals Inc. benefit from macro trendsInsider Buying & Weekly Stock Performance Updates - newser.com
Why Tarsus Pharmaceuticals Inc. stock attracts high net worth investorsJuly 2025 Opening Moves & Safe Entry Zone Tips - newser.com
Tarsus Pharmaceuticals (NASDAQ:TARS) Trading 9.6% HigherTime to Buy? - MarketBeat
Tarsus Pharmaceuticals Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
TARS Shares Roar Back: Explore The Surge - timothysykes.com
BofA Securities Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Raises Target Price to $80 - 富途牛牛
Tarsus Pharmaceuticals Hits New 52-Week High of $59.77 - Markets Mojo
Tarsus Pharmaceuticals Hits Day High with Strong 7.29% Intraday Surge - Markets Mojo
Lyme Disease Market Growth Highlighted by Pipeline Advances and Expanding Patient Population | DelveInsight - GlobeNewswire Inc.
Using Bollinger Bands to evaluate Tarsus Pharmaceuticals Inc.Watch List & Fast Gaining Stock Strategy Reports - newser.com
Tarsus Pharmaceuticals stock hits 52-week high at 59.76 USD By Investing.com - Investing.com Nigeria
Tarsus Pharmaceuticals (NASDAQ:TARS) Sets New 12-Month HighShould You Buy? - MarketBeat
Tarsus Pharmaceuticals stock hits 52-week high at 59.76 USD - Investing.com
Is Tarsus Pharmaceuticals Inc a good long term investmentTrendline Breakouts & Watch Expert Picks Before They Rally - earlytimes.in
Tarsus Pharmaceuticals Inc (TARS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.74%
자본화:
|
볼륨(24시간):